Sequent Scientific, 512529, SEQUENT Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

2,328.21
N/A
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

2,684.36
N/A
3.83

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

12.05
6.45
1.43

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-3.33
-37.45
-43.62

PAT CAGR (%)

10 Years
5 Years
3 Years

0.93
-
-

P:E (Median)

8 Years
5 Years
3 Years

29.49
42.78
62.39

P:BV (Average)

8 Years
5 Years
3 Years

3.90
4.22
5.11

EV:EBITDA (Average)

8 Years
5 Years
3 Years

37.32
35.53
48.96

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 23 Jun 22 Var% Mar 23 Mar 22 Var% Dec 22 Dec 21 Var% Sep 22 Sep 21 Var%
Net Sales 40.42 64.86 -37.68% 46.59 63.67 -26.83% 57.00 59.19 -3.70% 54.23 50.11 8.22%
Expenses 49.49 66.85 -25.97% 52.64 58.46 -9.96% 65.75 56.41 16.56% 63.81 54.69 16.68%
EBITDA -9.07 -1.99 - -6.05 5.21 - -8.75 2.78 - -9.58 -4.58 -
EBIDTM -22.43% -3.07% -12.97% 8.19% -15.34% 4.70% -17.66% -9.14%
Other Income 9.70 5.88 64.97% 8.01 5.77 38.82% 7.62 5.70 33.68% 6.73 10.41 -35.35%
Interest 0.98 0.35 180.00% 0.87 0.61 42.62% 0.72 0.56 28.57% 0.57 0.28 103.57%
Depreciation 2.42 2.38 1.68% 2.33 2.34 -0.43% 2.15 2.40 -10.42% 2.25 2.54 -11.42%
PBT -9.03 1.16 - -1.23 8.04 - -3.99 5.52 - -5.68 3.01 -
Tax -2.23 0.32 - 0.42 1.39 -69.78% -2.77 1.04 - -1.63 -1.28 -
PAT -6.80 0.84 - -1.65 6.65 - -1.23 4.47 - -4.05 4.29 -
PATM -16.83% 1.30% -3.53% 10.44% -2.15% 7.56% -7.47% 8.56%
EPS -0.27 0.03 - -0.07 0.27 - -0.05 0.18 - -0.16 0.17 -

Description Jun 23 Jun 22 Var% Mar 23 Mar 22 Var% Dec 22 Dec 21 Var% Sep 22 Sep 21 Var%
Net Sales 333.21 341.32 -2.38% 366.67 383.71 -4.44% 375.31 358.05 4.82% 337.61 350.55 -3.69%
Expenses 341.44 339.21 0.66% 370.04 350.36 5.62% 364.98 321.83 13.41% 334.74 330.87 1.17%
EBITDA -8.24 2.12 - -3.37 33.35 - 10.34 36.22 -71.45% 2.87 19.68 -85.42%
EBIDTM -2.47% 0.62% -0.92% 8.69% 2.75% 10.12% 0.85% 5.61%
Other Income 0.79 0.88 -10.23% 1.74 3.77 -53.85% 2.86 3.67 -22.07% 0.91 0.74 22.97%
Interest 10.48 6.80 54.12% 10.87 6.04 79.97% 9.72 3.45 181.74% 8.12 3.26 149.08%
Depreciation 14.24 13.93 2.23% 14.71 12.93 13.77% 13.67 12.83 6.55% 13.38 13.21 1.29%
PBT -55.68 -20.93 - -88.80 18.15 - -10.20 23.61 - -17.72 3.95 -
Tax -21.00 -5.61 - 3.64 8.25 -55.88% -0.42 5.05 - -13.28 -9.88 -
PAT -34.68 -15.32 - -92.44 9.90 - -9.78 18.56 - -4.44 13.82 -
PATM -10.41% -4.49% -25.21% 2.58% -2.61% 5.18% -1.32% 3.94%
EPS -1.40 -0.60 - -3.75 0.36 - -0.36 0.69 - -0.15 0.58 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 198.24 222.69 219.63 265.46 227.33 166.26 271.20 105.87 394.59 444.82 445.08 Net Sales Growth -16.65% 1.39% -17.26% 16.77% 36.73% -38.69% 156.16% -73.17% -11.29% -0.06% Cost Of Goods Sold 123.38 135.92 108.66 108.87 113.04 94.62 161.37 72.47 218.33 229.86 245.55 Gross Profit 74.86 86.77 110.97 156.59 114.29 71.64 109.83 33.40 176.26 214.95 199.53 GP Margin 37.76% 38.96% 50.53% 58.99% 50.27% 43.09% 40.50% 31.55% 44.67% 48.32% 44.83% Total Expenditure 231.69 249.09 231.59 241.50 205.10 163.57 258.06 121.27 359.06 384.54 437.81 Power & Fuel Cost - 13.93 11.96 12.77 12.73 8.52 2.32 2.14 17.98 20.68 21.77 % Of Sales - 6.26% 5.45% 4.81% 5.60% 5.12% 0.86% 2.02% 4.56% 4.65% 4.89% Employee Cost - 36.66 27.38 22.42 17.10 10.71 25.12 17.90 38.84 45.47 42.87 % Of Sales - 16.46% 12.47% 8.45% 7.52% 6.44% 9.26% 16.91% 9.84% 10.22% 9.63% Manufacturing Exp. - 39.30 48.21 58.70 51.52 41.13 15.87 14.85 56.50 48.54 49.63 % Of Sales - 17.65% 21.95% 22.11% 22.66% 24.74% 5.85% 14.03% 14.32% 10.91% 11.15% General & Admin Exp. - 15.10 16.29 15.28 6.90 7.15 13.02 9.92 15.19 23.99 41.71 % Of Sales - 6.78% 7.42% 5.76% 3.04% 4.30% 4.80% 9.37% 3.85% 5.39% 9.37% Selling & Distn. Exp. - 1.85 2.16 4.02 2.11 1.04 0.83 0.47 4.03 5.71 7.90 % Of Sales - 0.83% 0.98% 1.51% 0.93% 0.63% 0.31% 0.44% 1.02% 1.28% 1.77% Miscellaneous Exp. - 6.34 16.94 19.45 1.68 0.40 39.53 3.53 8.19 10.29 7.90 % Of Sales - 2.85% 7.71% 7.33% 0.74% 0.24% 14.58% 3.33% 2.08% 2.31% 6.37% EBITDA -33.45 -26.40 -11.96 23.96 22.23 2.69 13.14 -15.40 35.53 60.28 7.27 EBITDA Margin -16.87% -11.86% -5.45% 9.03% 9.78% 1.62% 4.85% -14.55% 9.00% 13.55% 1.63% Other Income 32.06 28.29 38.86 31.30 14.56 13.96 24.67 19.07 15.55 3.56 5.25 Interest 3.14 2.51 1.61 2.68 5.04 3.22 4.54 0.42 16.44 47.46 38.74 Depreciation 9.15 9.12 9.59 9.13 8.95 7.22 14.37 3.25 24.18 26.38 27.13 PBT -19.93 -9.75 15.69 43.45 22.81 6.20 18.90 -0.01 10.46 -9.99 -53.34 Tax -6.21 -3.67 0.89 8.77 1.47 -1.38 2.87 0.00 0.07 1.70 0.00 Tax Rate 31.16% 37.64% 5.67% 21.45% 6.44% -22.26% 0.70% 0.00% 0.67% 3.95% 0.00% PAT -13.73 -6.08 14.80 32.11 21.34 7.59 406.41 -0.01 10.39 41.31 -114.42 PAT before Minority Interest -13.73 -6.08 14.80 32.11 21.34 7.59 406.41 -0.01 10.39 41.31 -114.42 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -6.93% -2.73% 6.74% 12.10% 9.39% 4.57% 149.86% -0.01% 2.63% 9.29% -25.71% PAT Growth -184.49% - -53.91% 50.47% 181.16% -98.13% - - -74.85% - EPS -0.55 -0.24 0.59 1.29 0.86 0.30 16.30 0.00 0.42 1.66 -4.59

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 1,412.80 1,420.91 1,412.82 1,361.62 1,179.24 1,039.31 1,030.59 683.57 624.98 465.36 455.46 Net Sales Growth -1.45% 0.57% 3.76% 15.47% 13.46% 0.85% 50.77% 9.37% 34.30% 2.17% Cost Of Goods Sold 831.87 833.77 793.00 694.65 605.05 543.01 554.23 356.70 311.71 240.72 243.65 Gross Profit 580.93 587.14 619.82 666.96 574.19 496.30 476.36 326.87 313.27 224.65 211.81 GP Margin 41.12% 41.32% 43.87% 48.98% 48.69% 47.75% 46.22% 47.82% 50.12% 48.27% 46.50% Total Expenditure 1,411.20 1,408.95 1,303.43 1,151.68 1,008.92 914.37 919.10 643.03 568.27 444.87 438.68 Power & Fuel Cost - 42.45 33.86 28.75 24.73 23.06 14.66 12.77 26.51 23.32 22.06 % Of Sales - 2.99% 2.40% 2.11% 2.10% 2.22% 1.42% 1.87% 4.24% 5.01% 4.84% Employee Cost - 258.38 231.37 187.22 165.06 145.95 132.07 106.22 88.62 62.39 48.12 % Of Sales - 18.18% 16.38% 13.75% 14.00% 14.04% 12.81% 15.54% 14.18% 13.41% 10.57% Manufacturing Exp. - 85.14 93.67 96.18 83.24 77.73 59.07 57.63 72.14 54.31 52.30 % Of Sales - 5.99% 6.63% 7.06% 7.06% 7.48% 5.73% 8.43% 11.54% 11.67% 11.48% General & Admin Exp. - 75.80 66.90 58.40 56.37 58.35 70.92 48.60 36.44 33.79 43.58 % Of Sales - 5.33% 4.74% 4.29% 4.78% 5.61% 6.88% 7.11% 5.83% 7.26% 9.57% Selling & Distn. Exp. - 58.00 57.11 50.00 45.16 36.29 36.87 28.78 17.46 20.27 12.30 % Of Sales - 4.08% 4.04% 3.67% 3.83% 3.49% 3.58% 4.21% 2.79% 4.36% 2.70% Miscellaneous Exp. - 55.42 27.52 36.47 29.32 29.98 51.29 32.34 15.40 10.07 12.30 % Of Sales - 3.90% 1.95% 2.68% 2.49% 2.88% 4.98% 4.73% 2.46% 2.16% 3.66% EBITDA 1.60 11.96 109.39 209.94 170.32 124.94 111.49 40.54 56.71 20.49 16.78 EBITDA Margin 0.11% 0.84% 7.74% 15.42% 14.44% 12.02% 10.82% 5.93% 9.07% 4.40% 3.68% Other Income 6.30 6.39 10.86 10.49 10.09 8.67 17.20 11.08 14.30 9.96 3.84 Interest 39.19 35.52 15.77 24.38 35.71 32.80 39.70 28.34 38.56 44.37 39.04 Depreciation 56.00 55.69 51.54 50.60 50.62 41.92 53.30 40.07 46.22 32.94 32.60 PBT -172.40 -72.86 52.93 145.45 94.08 58.88 35.70 -16.80 -13.77 -46.85 -51.00 Tax -31.06 -15.68 8.17 32.18 12.03 2.01 13.46 -0.41 2.62 3.39 0.58 Tax Rate 18.02% 11.39% 15.44% 23.55% 12.79% 3.41% 3.03% 2.44% -19.03% -40.50% -0.53% PAT -141.34 -121.16 40.95 95.44 69.91 48.66 421.57 -13.83 -18.47 -10.74 -110.49 PAT before Minority Interest -141.04 -121.98 44.76 104.45 82.05 56.88 430.83 -16.39 -16.39 -11.76 -110.49 Minority Interest 0.30 0.82 -3.81 -9.01 -12.14 -8.22 -9.26 2.56 -2.08 1.02 0.00 PAT Margin -10.00% -8.53% 2.90% 7.01% 5.93% 4.68% 40.91% -2.02% -2.96% -2.31% -24.26% PAT Growth -624.26% - -57.09% 36.52% 43.67% -88.46% - - - - EPS -5.67 -4.86 1.64 3.83 2.80 1.95 16.90 -0.55 -0.74 -0.43 -4.43

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 1,058.36 1,041.09 1,029.51 886.22 917.79 948.62 1,257.33 1,205.88 156.92 50.25 Share Capital 49.89 49.67 49.67 49.67 49.37 48.75 48.75 47.65 30.48 26.74 Total Reserves 952.25 944.32 972.07 822.45 849.53 882.29 1,193.03 1,134.19 92.50 11.15 Non-Current Liabilities 12.44 19.26 4.80 11.50 36.20 19.01 38.28 42.08 79.95 109.66 Secured Loans 0.00 0.00 0.00 15.16 20.61 0.00 13.98 23.82 56.70 90.47 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.35 0.56 Long Term Provisions 24.40 24.51 6.59 4.09 22.30 24.39 28.88 22.84 22.97 18.70 Current Liabilities 70.24 89.56 96.62 105.24 79.87 26.69 168.71 109.89 427.45 414.42 Trade Payables 36.71 57.56 58.75 64.34 52.60 24.56 69.96 73.64 69.81 135.38 Other Current Liabilities 4.67 5.20 2.85 9.30 6.01 1.91 35.29 20.85 86.85 31.38 Short Term Borrowings 19.10 15.50 5.22 14.39 19.27 0.00 63.22 15.04 270.29 241.08 Short Term Provisions 9.77 11.30 29.81 17.22 1.99 0.21 0.24 0.36 0.51 6.58 Total Liabilities 1,141.04 1,149.91 1,130.93 1,002.96 1,033.86 994.32 1,464.32 1,357.85 664.32 574.33 Net Block 56.72 66.90 65.78 69.41 52.42 23.68 181.67 169.60 200.88 219.93 Gross Block 110.96 113.09 102.86 99.30 73.33 37.61 230.34 193.00 302.01 338.33 Accumulated Depreciation 54.24 46.19 37.08 29.89 20.90 13.93 48.67 23.40 101.13 118.40 Non Current Assets 1,047.29 995.04 985.95 879.01 946.46 853.77 1,095.85 1,056.39 421.95 333.95 Capital Work in Progress 2.20 1.40 4.34 3.72 0.03 3.12 32.26 19.97 8.93 11.12 Non Current Investment 632.47 658.47 685.11 738.95 788.16 672.67 834.62 834.87 183.11 65.04 Long Term Loans & Adv. 355.33 267.65 230.43 65.53 83.27 138.79 26.79 23.08 26.30 36.20 Other Non Current Assets 0.57 0.61 0.29 1.39 22.57 15.51 20.52 8.86 2.73 1.66 Current Assets 83.66 154.86 144.99 123.95 87.41 140.54 368.46 301.47 242.38 240.38 Current Investments 0.05 0.14 0.07 18.75 0.10 13.98 62.28 62.29 0.08 0.08 Inventories 47.95 67.99 45.79 31.42 25.33 13.83 62.53 56.19 66.88 101.25 Sundry Debtors 13.65 52.42 61.44 40.79 42.90 78.47 113.03 73.75 98.77 79.66 Cash & Bank 0.18 12.89 0.74 3.72 1.88 3.04 3.06 4.80 27.38 19.13 Other Current Assets 21.84 1.74 3.56 3.61 17.21 31.22 127.56 104.45 49.28 40.26 Short Term Loans & Adv. 20.84 19.69 33.40 25.66 15.65 30.09 114.68 86.38 30.28 36.32 Net Current Assets 13.42 65.31 48.37 18.71 7.54 113.85 199.75 191.58 -185.08 -174.04 Total Assets 1,130.95 1,149.90 1,130.94 1,002.96 1,033.87 994.31 1,464.31 1,357.86 664.33 574.33

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 698.78 692.10 727.65 687.10 706.69 647.58 976.79 945.71 91.27 56.73 Share Capital 49.89 49.67 49.67 49.67 49.37 48.75 48.75 47.65 30.48 26.74 Total Reserves 592.57 595.33 670.21 623.34 638.43 581.25 912.49 874.01 26.85 -0.37 Non-Current Liabilities 258.11 209.11 153.58 216.46 214.75 227.13 246.20 299.72 277.55 159.23 Secured Loans 127.17 87.25 62.52 108.88 126.94 85.14 141.76 197.50 249.97 150.52 Unsecured Loans 55.63 35.21 31.18 41.18 20.90 18.40 23.38 13.82 0.35 0.56 Long Term Provisions 71.08 55.95 27.19 13.16 30.50 28.54 34.76 28.66 25.70 8.03 Current Liabilities 558.75 537.35 513.11 514.86 440.41 430.93 663.55 290.37 406.09 405.28 Trade Payables 244.34 258.05 226.91 220.38 209.35 160.49 203.04 143.94 90.94 114.59 Other Current Liabilities 76.88 78.99 100.64 104.98 87.80 106.52 259.26 83.23 107.43 56.80 Short Term Borrowings 182.09 159.54 102.91 147.12 127.36 152.41 194.70 56.04 204.31 226.60 Short Term Provisions 55.45 40.77 82.66 42.38 15.90 11.51 6.54 7.17 3.42 7.29 Total Liabilities 1,566.05 1,486.57 1,443.00 1,463.16 1,402.10 1,342.62 1,903.76 1,538.02 921.84 625.82 Net Block 605.31 564.44 535.66 576.57 498.14 475.97 684.33 586.48 474.43 237.59 Gross Block 939.83 825.09 753.25 762.46 638.06 581.74 789.60 643.70 596.25 369.07 Accumulated Depreciation 334.52 260.64 217.60 185.89 139.91 105.77 105.27 57.22 121.82 131.48 Non Current Assets 743.48 678.16 676.33 738.86 795.99 804.61 1,176.02 1,047.48 612.00 359.87 Capital Work in Progress 55.28 11.63 30.79 13.42 22.61 18.04 32.55 23.52 39.06 43.04 Non Current Investment 0.01 36.79 76.94 131.29 179.65 221.73 363.97 360.58 58.04 0.04 Long Term Loans & Adv. 71.33 53.92 32.15 14.40 32.27 31.01 37.51 30.35 36.01 76.06 Other Non Current Assets 11.55 11.37 0.79 3.18 63.31 57.86 57.66 46.54 4.47 3.15 Current Assets 812.48 808.41 766.68 724.30 606.12 538.01 727.74 490.54 309.84 265.94 Current Investments 0.05 1.44 5.66 40.18 0.47 17.34 64.12 66.98 0.58 0.08 Inventories 346.09 347.97 264.36 219.42 200.10 158.57 160.81 135.08 94.36 101.40 Sundry Debtors 340.96 329.24 346.14 318.76 278.25 258.35 254.62 192.39 115.44 83.54 Cash & Bank 41.75 59.25 56.20 75.83 72.04 42.45 47.40 25.30 38.46 36.21 Other Current Assets 83.64 7.68 16.82 14.79 55.26 61.30 200.79 70.80 61.01 44.71 Short Term Loans & Adv. 75.90 62.83 77.52 55.33 46.75 56.05 54.48 46.69 41.86 37.47 Net Current Assets 253.73 271.06 253.57 209.44 165.71 107.08 64.19 200.17 -96.25 -139.34 Total Assets 1,555.96 1,486.57 1,443.01 1,463.16 1,402.11 1,342.62 1,903.76 1,538.02 921.84 625.81

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 37.75 9.36 2.34 30.20 73.80 -4.02 -24.04 100.02 -24.99 -42.37 PBT -9.75 15.69 43.45 22.81 6.20 409.27 -0.01 10.46 43.01 -114.42 Adjustment -0.49 -6.38 1.12 1.74 -2.19 -392.74 20.30 33.58 22.54 136.20 Changes in Working Capital 48.68 1.81 -25.47 7.84 70.32 -21.10 -42.97 56.92 -89.22 -63.80 Cash after chg. in Working capital 38.45 11.12 19.09 32.39 74.34 -4.57 -22.68 100.95 -23.68 -42.01 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.70 -1.75 -16.76 -2.19 -0.54 0.55 -1.36 -0.93 -1.31 -0.35 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -50.70 -4.25 16.55 -17.68 -114.06 15.60 -46.84 -359.41 23.65 -60.82 Net Fixed Assets 1.33 -7.29 -4.18 -29.66 -32.63 221.87 -49.63 97.97 38.51 -26.62 Net Investments 26.09 26.57 72.52 30.56 -101.61 210.25 0.26 -713.97 -118.07 -10.37 Others -78.12 -23.53 -51.79 -18.58 20.18 -416.52 2.53 256.59 103.21 -23.83 Cash from Financing Activity 0.24 7.25 -21.33 -10.71 40.34 -11.78 70.97 247.38 7.96 107.56 Net Cash Inflow / Outflow -12.71 12.36 -2.44 1.81 0.07 -0.19 0.09 -12.01 6.62 4.37 Opening Cash & Equivalents 12.80 0.44 2.87 1.07 1.00 1.19 1.10 13.11 6.48 2.11 Closing Cash & Equivalent 0.08 12.80 0.44 2.87 1.07 1.00 1.19 1.10 13.10 6.48

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 16.81 30.59 114.75 115.33 116.02 45.24 -7.19 -0.05 -23.55 -44.78 PBT -137.66 52.93 145.45 94.08 58.88 445.79 -16.80 -13.77 -8.37 -109.91 Adjustment 220.72 93.73 83.98 91.41 84.47 -313.85 123.31 83.81 35.92 133.52 Changes in Working Capital -51.61 -89.30 -70.89 -58.30 -27.95 -77.87 -104.37 -71.46 -53.98 -67.45 Cash after chg. in Working capital 31.45 57.36 158.55 127.18 115.40 54.06 2.14 -1.42 -26.44 -43.84 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -14.64 -26.77 -43.79 -11.85 0.62 -8.83 -9.33 1.37 2.89 -0.95 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -64.96 -95.57 9.65 -72.27 -67.69 7.17 -116.18 -315.83 -154.69 -79.95 Net Fixed Assets 1.33 -7.29 -4.18 -29.66 -32.63 221.87 -49.63 97.97 38.51 -26.62 Net Investments 26.09 26.57 72.52 30.56 -101.61 210.25 0.26 -713.97 -118.07 -10.37 Others -92.38 -114.85 -58.69 -73.17 66.55 -424.95 -66.81 300.17 -75.13 -42.96 Cash from Financing Activity 32.23 67.26 -138.75 -42.75 -20.08 -56.96 147.44 308.69 179.41 145.54 Net Cash Inflow / Outflow -15.92 2.29 -14.35 0.31 28.25 -4.55 24.07 -7.19 1.17 20.80 Opening Cash & Equivalents 57.50 53.74 68.10 67.79 39.54 44.10 20.03 21.85 22.96 3.45 Closing Cash & Equivalent 41.57 57.50 53.74 68.10 67.79 39.54 44.10 20.03 21.83 22.96

Financial Ratios

Consolidated /

Standalone

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 40.18 40.02 41.14 35.11 36.41 38.20 50.95 49.61 8.07 2.83 ROA -0.53% 1.30% 3.01% 2.10% 0.75% 33.06% 0.00% 1.03% 6.67% -20.48% ROE -0.61% 1.47% 3.39% 2.41% 0.83% 37.41% 0.00% 1.59% 51.35% -168.93% ROCE -0.68% 1.65% 4.45% 2.96% 0.99% 36.09% 0.03% 3.07% 20.15% -19.54% Fixed Asset Turnover 2.01 2.04 2.66 2.66 3.00 2.05 0.52 1.65 1.45 1.45 Receivable days 53.54 94.31 69.43 66.55 132.93 127.17 310.76 77.04 70.28 58.94 Inventory Days 93.97 94.25 52.44 45.13 42.89 50.71 197.54 54.96 66.23 72.35 Payable days 126.58 195.35 206.34 103.60 86.82 78.05 239.99 74.47 102.24 128.36 Cash Conversion Cycle 20.93 -6.79 -84.46 8.08 88.99 99.83 268.31 57.53 34.27 2.92 Total Debt/Equity 0.02 0.02 0.01 0.04 0.05 0.00 0.07 0.04 2.77 9.23 Interest Cover -2.88 10.75 16.26 5.53 2.93 91.09 0.97 1.64 1.91 -1.95

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 25.76 25.97 28.98 27.10 27.86 25.85 39.44 38.69 3.76 1.97 ROA -7.99% 3.06% 7.19% 5.73% 4.14% 26.54% -0.95% -1.33% -1.52% -18.19% ROE -18.95% 6.56% 15.00% 12.06% 8.63% 54.15% -1.74% -3.35% -28.10% -201.83% ROCE -9.71% 7.01% 16.24% 12.59% 9.24% 41.28% 0.87% 2.72% 6.93% -16.09% Fixed Asset Turnover 1.65 1.83 1.80 1.72 1.74 1.51 0.96 1.03 1.01 1.36 Receivable days 84.11 85.48 89.12 90.45 92.53 90.49 118.40 87.75 74.80 57.30 Inventory Days 87.10 77.50 64.84 63.56 61.85 56.34 78.37 65.41 73.58 71.75 Payable days 109.97 111.61 117.51 80.72 75.36 77.04 104.11 77.28 87.31 115.68 Cash Conversion Cycle 61.25 51.38 36.45 73.29 79.02 69.78 92.66 75.87 61.07 13.36 Total Debt/Equity 0.62 0.49 0.31 0.51 0.47 0.48 0.43 0.34 8.26 15.86 Interest Cover -2.88 4.36 6.60 3.63 2.80 12.19 0.41 0.64 0.81 -1.82

Top Investors:

unit trust of india investment advisory services l

ashoka india opportunities fund

public sector pension investment board - iifl asse

investor education and protection fund (iepf)

Annual Reports:

News Update:

USFDA completes inspection at Sequent Scientific’s Visakhapatnam manufacturing facility
25th Sep 2023, 10:37 AM

At the end of the inspection, the company has been issued a Form 483 with one observation
Read More
Sequent Scientific gets nod to sell API facility in Tarapur
15th Sep 2023, 11:43 AM

The Board of Directors at its meeting held on September 14, 2023 considered and approved the same
Read More
Sequent Scientific - Quarterly Results
10th Aug 2023, 22:13 PM

Read More

Sequent Scientific Ltd.

Pharmaceuticals & Drugs - Veterinary

BSE: 512529 | NSE: SEQUENT

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Sequent Scientific Ltd.

Pharmaceuticals & Drugs - Veterinary

BSE: 512529 | NSE: SEQUENT

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: